At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Proton radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Trial of Lumpectomy and Partial Breast Proton Therapy for Early Stage Breast Cancer
In Brief
A clinical study evaluating Proton radiation therapy for Early-Stage Breast Cancer. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if partial breast proton therapy is effective treatment for early stage breast cancer following lumpectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEarly-Stage Breast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2004
First PostedFeb 2008
Primary CompletionMay 2020
TodayJul 2026
First PostedFeb 13, 2008
Enrollment StartFeb 1, 2004
Primary CompletionMay 12, 2020
TodayJul 2, 2026
Enrollment to primary: 16.3 yearsPosted 18.4 years ago
Interventions
Proton radiation therapyradiation
Proton radiotherapy will start 2-4 weeks following surgical excision. The treatment area will include the lumpectomy site with an additional margin. Daily proton therapy will be given as an out-patient over a two week coarse.